cisplatin,pembrolizumab,Vibostolimab,Favezelimab
merck
['mibc', 'pembro', ' cis ', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
excellent summary of updates in bcg unresponsive #nmibc at #gu23 with fda approved: pembrolizumab adstilladrin
others: gem/doce and n-803+bcg 
Medical oncologist @GACancerCenter, Augusta University specializing in genitourinary &breast oncology. Editor and TB moderator @themednet.org #patientadvocate